Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Exchange Rate Effect: 2011-2025

Historic Exchange Rate Effect for Prestige Consumer Healthcare (PBH) over the last 15 years, with Sep 2025 value amounting to -$4,000.

  • Prestige Consumer Healthcare's Exchange Rate Effect fell 100.56% to -$4,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 151.56%. This contributed to the annual value of -$573,000 for FY2025, which is 418.33% down from last year.
  • Prestige Consumer Healthcare's Exchange Rate Effect amounted to -$4,000 in Q3 2025, which was down 100.48% from $825,000 recorded in Q2 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Exchange Rate Effect ranged from a high of $1.4 million in Q4 2023 and a low of -$2.1 million during Q4 2024.
  • In the last 3 years, Prestige Consumer Healthcare's Exchange Rate Effect had a median value of -$3,000 in 2023 and averaged $38,636.
  • Examining YoY changes over the last 5 years, Prestige Consumer Healthcare's Exchange Rate Effect showed a top increase of 573.57% in 2024 and a maximum decrease of 20,066.67% in 2024.
  • Prestige Consumer Healthcare's Exchange Rate Effect (Quarterly) stood at -$230,000 in 2021, then surged by 446.96% to $798,000 in 2022, then soared by 77.32% to $1.4 million in 2023, then slumped by 246.71% to -$2.1 million in 2024, then crashed by 100.56% to -$4,000 in 2025.
  • Its Exchange Rate Effect was -$4,000 in Q3 2025, compared to $825,000 in Q2 2025 and $129,000 in Q1 2025.